Latest Tenofovir Stories
CONRAD Head of drug delivery, Meredith Clark, PhD, today presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in San Antonio, Texas.
The HIV/AIDS epidemic often has a woman's face because the proportion of women infected with HIV has been on the rise for a decade.
New research from the Centers for Disease Control and Prevention suggests that the HIV drug teneofovir can also prevent the contraction of the virus for intravenous drug users.
A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally.
Replacing brand-name drugs recommended for control of HIV infection with generic medications could save nearly $1 billion a year on health care costs in the US.
- A young chicken: also used as a pet name for children.